Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 2/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.61 |
| ▸ | GSK3B | P49841 | 2/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.57 |
| ▸ | CES2 | O00748 | 1/20 | 0.55 |
| ▸ | CES1 | P23141 | 1/20 | 0.55 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.49 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29987081 | 0.84 | PTPN1 (0.75) | MMP1PTPN1GSK3BHDAC1HDAC8 | |
| SCHEMBL26135918 | 0.79 | MMP1 (0.76) | MMP1PTPN1GSK3BHDAC1HDAC8 | |
| SCHEMBL18282694 | 0.79 | PTPN1 (0.58) | MMP1PTPN1GSK3BHDAC1HDAC8 | |
| SCHEMBL1643579 | 0.78 | PTPN1 (0.73) | MMP1PTPN1GSK3BHDAC1HDAC8 | |
| SCHEMBL2074662 | 0.78 | PTPN1 (0.68) | MMP1PTPN1GSK3BHDAC1HDAC8 | |
| SCHEMBL1360049 | 0.78 | PTPN1 (0.68) | MMP1PTPN1GSK3BHDAC1HDAC8 | |
| SCHEMBL23014264 | 0.78 | PTPN1 (0.57) | MMP1PTPN1GSK3BHSD11B1PDPK1 | |
| SCHEMBL11095198 | 0.78 | PTPN1 (0.67) | MMP1PTPN1GSK3BHDAC1HDAC8 | |
| SCHEMBL26978298 | 0.78 | PTPN1 (0.57) | MMP1PTPN1GSK3BHDAC1HDAC8 | |
| SCHEMBL22130998 | 0.77 | PTPN1 (0.71) | MMP1PTPN1GSK3BHDAC1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200187501-A1 | DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200187501-A1 | DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT | NOX1, L3MBTL1, MRM1 | MMP1 3166/4885PTPN1 950/4885GSK3B 4263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.